Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endoscopic sphincterotomy without fluoroscopic control in pregnancy

T Zágoni, Z Tulassay

    The American Journal of Gastroenterology
    |June 1, 1995
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Analysis of microRNA expression in brush cytology specimens improves the diagnosis of pancreatobiliary cancer.

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2019
    Same author

    Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence.

    Alimentary pharmacology & therapeutics·2017
    Same author

    Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study.

    Alimentary pharmacology & therapeutics·2016
    Same author

    Letter: dermatological complications with therapy for inflammatory bowel disease.

    Alimentary pharmacology & therapeutics·2013
    Same author

    Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-gene interactions in inflammatory bowel disease.

    International journal of immunogenetics·2012
    Same author

    Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease.

    Alimentary pharmacology & therapeutics·2011